Distinguished Scientist and Director, Deeley Research Centre, Co-Director, Cancer Immunotherapy Program, BC Cancer Agency
BIOGRAPHY
Speaker
Abstract
Immunotherapy: An unprecedented opportunity
-Long-lasting/curative treatments
-Lower side effects
-Wide applicability
-Natural mechanism of action
-Locally produced T cell therapies
-jobs
-talent
-innovation
-intellectual property
-cost control
You May Also Like
SEP 26, 2023 | 8:00 AM
Join us for an educational webinar that delves into the fascinating world of Extracellular Vesicles (EVs) and their impact on biomedical research and medicine. In collaboration with ExoVecto...
JUL 20, 2023 | 8:00 AM
Single-cell ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing, scATAC-seq) is a relatively new and powerful technique that allows researchers to identify open chromatin r...
SEP 13, 2023 | 10:00 AM
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
September 13 at 10:00am CEST, 9:00am BST
Webinar airing too early or too late for you? This webinar will also be available: September 13 at 10:00am PDT, 1:00pm EDT https://www.labroots.com/ms/webinar/dpcr-liquidbiopsy-panel-2 and S...
September 13 at 9:30am IST, 12:00pm CST/SGT
Liquid biopsy is an emerging area of clinical research, particularly in the context of cancer. As a minimally invasive complementary or alternative approach to tissue biopsies, liquid biopsi...
OCT 24, 2023 | 10:00 AM
Dynamic changes in chromatin drive gene expression programs during cellular development and contribute to pathological changes underlying disease. To date, efforts to characterize chromatin...
Loading Comments...
Finish Registering
-
JUN 08, 20232023 Lab Compliance Connect -
-
NOV 01, 2023CRISPR Virtual Event Series 2023
- See More
